Different Glycemic Index (GI) Values in 7 Food Products

NCT ID: NCT02278380

Last Updated: 2015-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-06-30

Study Completion Date

2015-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is initiated to investigate the glycemic index value of seven food products.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glycemic Index

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1

To compare the Glycemic Index value of seven test foods:

Low GI standard Breakfast Medium GI standard Breakfast Nutritional pregnant milk supplement Nutritional product for diabetics Pregnant and lactation women milk powder Nutritional drinks for diabetics Test product

Group Type OTHER

Low GI Standard Breakfast

Intervention Type OTHER

Low GI Standard Breakfast

Medium GI Standard Breakfast

Intervention Type OTHER

Medium GI Standard Breakfast

Enfamama A+

Intervention Type OTHER

Nutritional pregnant milk supplement

Glucerna Triple Care

Intervention Type OTHER

Nutritional product for diabetics

Dumex Precima

Intervention Type OTHER

Pregnant and lactation women milk powder

Diasip

Intervention Type OTHER

Nutritional drinks for diabetics

Test product

Intervention Type OTHER

Test product not patented yet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low GI Standard Breakfast

Low GI Standard Breakfast

Intervention Type OTHER

Medium GI Standard Breakfast

Medium GI Standard Breakfast

Intervention Type OTHER

Enfamama A+

Nutritional pregnant milk supplement

Intervention Type OTHER

Glucerna Triple Care

Nutritional product for diabetics

Intervention Type OTHER

Dumex Precima

Pregnant and lactation women milk powder

Intervention Type OTHER

Diasip

Nutritional drinks for diabetics

Intervention Type OTHER

Test product

Test product not patented yet

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Not patented yet, cannot disclose name.

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy males or non-pregnant females at least 6 weeks postpartum, non-lactating and aged 21-60yrs old in both groups.
* They should not suffer from any chronic diseases.
* no known food allergy or intolerance.
* no medications known to affect glucose tolerance(excluding oral contraceptives). Note: stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable.

Exclusion Criteria

* Age less than 21 years old and greater than 60 years old.
* known history of diabetes mellitus or the use of antihyperglycemic drugs or insulin to treat diabetes and related conditions.
* known history of AIDS, hepatitis, renal or heart disease or any other serious complications that may interfere with glucose metabolism.
* subjects using any medication (eg steroids, protease inhibitors or antipsychotics, etc.) that would interfere with the digestion and nutrient absorption.,
* subjects having gastrointestinal diseases that may interfere with nutrient absorption, distribution, metabolism, excretion and have no known food allergies.
* a major medical or surgical event requiring hospitalisation within the preceding 3 months.
Minimum Eligible Age

21 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Danone Asia Pacific Holdings Pte, Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kalpana Bhaskaran, Dr

Role: PRINCIPAL_INVESTIGATOR

Temasek Polytechnic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Temasek Polytechnic

Singapore, , Singapore

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Singapore

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GDM.1.C/D

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

DIAgnosing GDM usiNg Oral Sugar InStead
NCT05115188 COMPLETED PHASE2